Literature DB >> 20080539

The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase.

Stephan Philipp1, Malte Puchert, Sabine Adam-Klages, Vladimir Tchikov, Supandi Winoto-Morbach, Sabine Mathieu, Andrea Deerberg, Ljudmila Kolker, Norma Marchesini, Dieter Kabelitz, Yusuf A Hannun, Stefan Schütze, Dieter Adam.   

Abstract

The phospholipase neutral sphingomyelinase (N-SMase) has been recognized as a major mediator of processes such as inflammation, development and growth, differentiation and death of cells, as well as in diseases such as Alzheimer's, atherosclerosis, heart failure, ischemia/reperfusion damage, or combined pituitary hormone deficiency. Although activation of N-SMase by the proinflammatory cytokine TNF was described almost two decades ago, the underlying signaling pathway is unresolved. Here, we identify the Polycomb group protein EED (embryonic ectodermal development) as an interaction partner of nSMase2. In yeast, the N terminus of EED binds to the catalytic domain of nSMase2 as well as to RACK1, a protein that modulates the activation of nSMase2 by TNF in concert with the TNF receptor 1 (TNF-R1)-associated protein FAN. In mammalian cells, TNF causes endogenous EED to translocate from the nucleus and to colocalize and physically interact with both endogenous nSMase2 and RACK1. As a consequence, EED and nSMase2 are recruited to the TNF-R1.FAN.RACK1-complex in a timeframe concurrent with activation of nSMase2. After knockdown of EED by RNA interference, the TNF-dependent activation of nSMase2 is completely abrogated, identifying EED as a protein that both physically and functionally couples TNF-R1 to nSMase2, and which therefore represents the "missing link" that completes one of the last unresolved signaling pathways of TNF-R1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20080539      PMCID: PMC2824292          DOI: 10.1073/pnas.0908486107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice.

Authors:  D Kreder; O Krut; S Adam-Klages; K Wiegmann; G Scherer; T Plitz; J M Jensen; E Proksch; J Steinmann; K Pfeffer; M Krönke
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase.

Authors:  Jens Neumeyer; Cora Hallas; Oliver Merkel; Supandi Winoto-Morbach; Marten Jakob; Lutz Thon; Dieter Adam; Wulf Schneider-Brachert; Stefan Schütze
Journal:  Exp Cell Res       Date:  2006-04-24       Impact factor: 3.905

Review 3.  Structural basis of integrin regulation and signaling.

Authors:  Bing-Hao Luo; Christopher V Carman; Timothy A Springer
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 4.  The extended family of neutral sphingomyelinases.

Authors:  Christopher J Clarke; Christopher F Snook; Motohiro Tani; Nabil Matmati; Norma Marchesini; Yusuf A Hannun
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

5.  The human WD repeat protein WAIT-1 specifically interacts with the cytoplasmic tails of beta7-integrins.

Authors:  M Rietzler; M Bittner; W Kolanus; A Schuster; B Holzmann
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

6.  Neutral sphingomyelinases and nSMase2: bridging the gaps.

Authors:  Christopher J Clarke; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2006-07-21

7.  Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development.

Authors:  Wilhelm Stoffel; Britta Jenke; Barbara Blöck; Markus Zumbansen; Jürgen Koebke
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-11       Impact factor: 11.205

8.  Polycomb group protein ezh2 controls actin polymerization and cell signaling.

Authors:  I-hsin Su; Marc-Werner Dobenecker; Ephraim Dickinson; Matthew Oser; Ashwin Basavaraj; Raphael Marqueron; Agnes Viale; Danny Reinberg; Christoph Wülfing; Alexander Tarakhovsky
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

9.  Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2.

Authors:  Christopher J Clarke; Thach-Giao Truong; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2006-11-03       Impact factor: 5.157

10.  Analysis of membrane topology of neutral sphingomyelinase 2.

Authors:  Motohiro Tani; Yusuf A Hannun
Journal:  FEBS Lett       Date:  2007-03-01       Impact factor: 4.124

View more
  31 in total

1.  Herpes simplex virus 1 ICP6 impedes TNF receptor 1-induced necrosome assembly during compartmentalization to detergent-resistant membrane vesicles.

Authors:  Mohammad Ali; Linda Roback; Edward S Mocarski
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

Review 2.  The neutral sphingomyelinase family: identifying biochemical connections.

Authors:  Christopher J Clarke; Bill X Wu; Yusuf A Hannun
Journal:  Adv Enzyme Regul       Date:  2010-10-28

3.  RACK1 modulates NF-κB activation by interfering with the interaction between TRAF2 and the IKK complex.

Authors:  Fan Yao; Ling-Yun Long; Yue-Zhen Deng; Yuan-Yuan Feng; Guo-Yuan Ying; Wen-Dai Bao; Guo Li; Dong-Xian Guan; Yin-Qiu Zhu; Jing-Jing Li; Dong Xie
Journal:  Cell Res       Date:  2013-12-10       Impact factor: 25.617

4.  Factor associated with neutral sphingomyelinase activity mediates navigational capacity of leukocytes responding to wounds and infection: live imaging studies in zebrafish larvae.

Authors:  Alexandra Boecke; Dirk Sieger; Cristian Dan Neacsu; Hamid Kashkar; Martin Krönke
Journal:  J Immunol       Date:  2012-07-16       Impact factor: 5.422

5.  Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.

Authors:  Sujatha Gurunathan; Jeffrey A Winkles; Sankar Ghosh; Matthew S Hayden
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

Review 6.  Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Authors:  Daniel Canals; David M Perry; Russell W Jenkins; Yusuf A Hannun
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

7.  ATRA transcriptionally induces nSMase2 through CBP/p300-mediated histone acetylation.

Authors:  Christopher J Clarke; Achraf A Shamseddine; Joseph J Jacob; Gabrielle Khalife; Tara A Burns; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2016-03-24       Impact factor: 5.922

8.  Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.

Authors:  Michael V Airola; Prajna Shanbhogue; Achraf A Shamseddine; Kip E Guja; Can E Senkal; Rohan Maini; Nana Bartke; Bill X Wu; Lina M Obeid; Miguel Garcia-Diaz; Yusuf A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

Review 9.  The roles of neutral sphingomyelinases in neurological pathologies.

Authors:  Charles R Horres; Yusuf A Hannun
Journal:  Neurochem Res       Date:  2012-01-12       Impact factor: 3.996

Review 10.  Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.

Authors:  Bill X Wu; Christopher J Clarke; Yusuf A Hannun
Journal:  Neuromolecular Med       Date:  2010-06-16       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.